Effect of fennel vaginal cream on sexual function in postmenopausal women: A double blind randomized controlled trial

Logo of jmedlife J Med Life. 2018 Jan-Mar; 11(1): 24–28. PMCID: PMC5909942 PMID: 29696061 Parvin Abedi,* Mahin Najafian,** Masumeh Yaralizadeh,*** and Foroogh Namjoyan**** Author information ► Article notes ► Copyright and License information ► Disclaimer Go to: Abstract Objective: The aim of this study was to assess the effect of fennel on sexual function in postmenopausal women. It was a randomized controlled trial in 60 postmenopausal women with sexual dysfunction who were randomly assigned to two groups receiving either fennel vaginal cream (n=30) or placebo (n=30). Vaginal atrophy in the women was assessed using symptoms such as pallor, dryness, dyspareunia, itching and burning. The pH of the vagina and cytology of the vaginal mucosa were also measured at baseline and 8 weeks after the intervention. All participants were requested to fill out the Female Sexual Function Index (FSFI) at baseline and after 8 weeks. The intervention group was requested to use fennel vaginal cream (5 grams) every night, while the control group used placebo each night for 8 weeks. The data were analyzed using the independent t-test and Chi-square, Mann-Whitney and Wilcoxon tests. All areas of sexual function including arousal, lubrication, orgasm, sexual satisfaction and pain improved in both fennel and placebo groups after 8 weeks; however, the differences in the fennel group were more evident (p<0.05). The total FSFI score was significantly higher in the fennel group compared to the control group (8.2 ±9.4 and 8.03±10.36 before the intervention and changing to 33.79±0.7 and 18.99±1.09 after the intervention in the fennel and placebo groups, respectively; p<0.001). Discussion: According to our results, fennel vaginal cream is an effective means of improving sexual activity in postmenopausal women. The use of this product in women who have sexual dysfunction and contraindications for hormone therapy is recommended. Keywords: Fennel vaginal cream, sexual function, sexual dysfunction, postmenopausal women Go to: Introduction Menopause is the permanent cessation of menstruation, and it is diagnosed by the lack of a menstrual period for at least 12 months [1]. Postmenopausal women experience physiological and psychological changes after menopause [2]. Some of the complications of menopause include hot flashes, insomnia, depression and dyspareunia [3]. Findings from the Global Study of Sexual Attitudes and Behaviors (GSSAB) involving 13,882 women in the 40-80 age range suggest that the prevalence of female sexual dysfunction (FSD) is 18 to 41%. The results of this study demonstrated that FSD may decrease the self-esteem and quality of life of women and may cause emotional distress [4]. A study conducted in Iran involving postmenopausal women showed that the prevalence of sexual dysfunction is 81.5% [5]. Estrogen is the most effective treatment for female sexual dysfunction that is approved by the US Food and Drug Administration (FDA) [6]. Estrogen given orally or vaginally can reduce vaginal dryness, vaginal atrophy and sexual dysfunction [7]. However, according to the results of the Women Health Initiative (WHI) study, hormone therapy did not improve general health, mental health, depression or sexual satisfaction among postmenopausal women [8]. The WHI study involving 16,608 postmenopausal women who were recruited to receive either estrogen and progesterone or placebo showed that after a 5.2-year follow-up, the risk of coronary heart disease, breast cancer, and endometrial cancer increased significantly among hormone users [9]. There are also natural treatments for sexual dysfunction. The results of some earlier studies showed that the herb Maca (Lepidiummeyenii) could significantly increase fertility and sexual activity in humans and animals [10]. In one study, niacin (1500 mg/day for 12 weeks) improved erectile problems in men compared to placebo [11]. Foeniculum vulgare or fennel is a plant in the carrot family and is indigenous to the shores of the Mediterranean Sea [12]. Iran is one of the producers of this plant. The main chemical compounds in fennel are trans-anethole and dianethole, which have estrogenic effects [13]. Using fennel significantly reduced hair thickness in women affected by hirsutism after 24 weeks [14]. The use of fennel for vaginal atrophy was assessed and approved for the first time in a recent study [15]. Also, the positive effect of fennel on sexual satisfaction in postmenopausal women has been reported in another study [16]. The purpose of the present study was to assess the effect of fennel on sexual function among postmenopausal women in Iran. Go to: Material and methods This was a randomized controlled trial in which 60 postmenopausal women were recruited and randomly assigned to two groups: fennel and placebo (n=30 in each group). The design of this study was approved by the Ethics Committee of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (Ref. No.: ajums.REC.1393.249). The protocol of this study was registered in the Iranian Randomized Controlled Trial Registry (Ref. No.: IRCT2014102919743N1). The inclusion criteria were as follows: women with age between 45 and 65 years, women who had natural menopause confirmed by amenorrhea for one year or increased follicle stimulation hormone (FSH)≥40 IU/l, women who lived with their husband and were sexually active, and score of Female Sexual Function Scale <26. Women with vaginal bleeding or infection, women who were receiving hormone therapy and women who used phytoestrogen, were excluded from the study. All eligible women gave written informed consent before data collection. The following equation was used for sample size calculation [17]: n=((s_1^2+s_2^2 ))/(x ®_1-x ®_2 )^2 〖(z_(1-α/2)+z_β)〗^2 In this formula, α = 0.05, β = 0.1, 1–β = 90%, P = 3.3%, p = 36%, and n = 26. The power of the study was set at 90%. We added 20% to the acquired number for attrition, and the total number of participants in each group was set at 30. Preparation of fennel and placebo Both fennel and placebo were made in the Pharmacology School Laboratory of Ahvaz Jundishapur University of Medical Sciences. Fennel seeds were mixed with ethanol 80% and stored for three days. The mixture was then dried using a rotary and freezer dryer. The dried fennel extract was mixed with 5% emulsion cream base. For preservation, propylparaben and methylparaben were added to oil and water phases, respectively. The fennel extract was mixed with a proper carrier and prepared with a concentration of 5% [18]. The placebo cream was manufactured using the proper carrier with a similar color and appearance to the fennel cream. Details of the preparation of fennel and placebo have been published previously [15]. Randomization Eligible women were randomly assigned into one of the two groups: fennel or placebo. Fennel vaginal cream or placebo was coded as “A” or “B” by a person who was not aware of the purpose of the study. One of the researchers (MY), who was not aware of the encoded fennel or placebo, was responsible for distributing the fennel cream or placebo to the women. Measures A demographic questionnaire and the Female Sexual Function Index (FSFI) were used to collect data. The FSFI contains 19 questions in six domains of the sexual function. In this questionnaire, two questions were dedicated to measuring sexual desire, four for measuring arousal, four for measuring lubrication, and three for measuring each orgasm, satisfaction and pain. The score of each domain was multiplied by a special factor; 0.6 for desire, 0.3 for arousal and lubrication and 0.4 for other areas of sexual function. The minimum and maximum scores for all domains are 2 and 36, respectively. A score less than 26 indicates sexual dysfunction. The validity and reliability of this questionnaire have been tested by Rosen et al. [19]. The reliability and validity of the Persian version of this questionnaire were evaluated in Iran by Fakhri et al., and the results showed that this questionnaire has acceptable validity and reliability for use in Iranian women [20]. All women were requested to complete the FSFI questionnaire at baseline and 8 weeks after the intervention, while one of the researchers (MY) was present to clarify any ambiguity for the participants. Postmenopausal women were also assessed regarding subjective and objective signs and symptoms of vaginal atrophy. The results of vaginal atrophy assessment were previously published [15]. Statistics All data were entered into Statistical Package for the Social Sciences (SPSS), version 22. Continuous data were tested for normality using the Kolmogorov-Smirnov test. The independent t-test and Mann-Whitney U test were used to compare the two groups regarding continuous data. The Wilcoxon signed-ranked test was used to compare sexual function before and after the intervention. The chi-square test was used to compare categorical data between the two groups. Go to: Results In this study, we did not have any drop-outs. Figure 1 indicates the recruitment and retention of the participants. The mean age of women in the fennel group was 53.73±3.6 and 52.9±3.4 years in the control group (p>0.05). The two groups did not show any significant difference regarding the age of menopause, body mass index, education or economic situation. Most women in the two groups had one coitus per week (43.3% vs. 40% in the fennel and control groups, respectively; p>0.05) (Table 1). An external file that holds a picture, illustration, etc. Object name is JMedLife-11-024-g001.jpg Open in a separate window Fig. 1 The flow diagram of recruitment and retention of participants in the study Table 1 The socio-demographic characteristics of participants in the Fennel and placebo groups Variables Fennel group n=30 Placebo group n=30 P value Mean±SD or N(%) Age (y) 53.73±3.6 52.9±3.4 0.36 Age of menopause (y) 49.5±1.99 49.3±1.9 0.32 Body mass index (kg/m2) 24.6±3.9 23.4±3.2 0.20 Education High school 20(66.7) 16(53.3) 0.50 Diploma 7(23.3) 8(26.7) University education 3910) 6(20) Job Employee 5(16.7) 4(13.3) 0.59 House keeper 23(76.7) 21(70) Retired 2(6.7) 5(16.7) Economic situation Weak 9(30) 11(36.70 0.83 Moderate 14(46.70 12(40) Well off 7(23.3) 7923.30 Numbers of coitus per week 0 2(6.7) 3(10) 0.94 1 13(43.3) 12(40) 2 6(20) 7(23.3) 3 7(23.3) 5(16.7) 4 4(6.7) 3(10) Open in a separate window Table 2 gives the mean score of the sexual function domain in the fennel and control groups. This table shows that desire increased in the fennel and control groups significantly after 8 weeks (from 2 ± 0.53 to 5.3±.36 in the fennel group, p<0.001; from 1.8±0.6 to 2.9±0.46 in the control group, p<0.001). Desire increased in the fennel group more than it did in the control group (p<0.001). Other domains of sexual function increased significantly in each group after 8 weeks; however, the fennel group showed significant improvement in all areas (p<0.001). Table 2 The mean score of the sexual function domain before and after the intervention in the two groups Variables Fennel (N=30) Control (N=30) P value between groups Before After Before After Mean ± SD Mean ± SD Desire 2 ± 0.53 5.3±0.36* 1.8±0.6 2.9±0.46* <0.001 Arousal 1.13±0.56 5.3±0.36* 1.13±0.66 2±0.32* <0.001 Lubrication 1.5±0.89 5.7±0.27* 3.6±0.86 3.3±0.38* <0.001 Orgasm 1.7±0.88 5.6±0.28* 1.8±1.09 3.4±0.48* <0.001 Sexual satisfaction 1.36±0.36 5.8±0.26* 1.28± 0.28 3.5±0.41* <0.001 Pain 1.45±0.78 5.8±0.24* 1.32±0.91 3.3±0.26* <0.001 Total score of sexual function 9.4±2.8 33.79±0.78* 10.36±8.03 18.9±1.09* <0.001 *P<0.001 Using Wilcoxon Signed Ranks Test The total FSFI score was significantly higher in the fennel group compared to the control group after the intervention (8.2 ±9.4 and 8.03±10.36 before intervention and 33.79±0.7 and 18.99±1.09 after the intervention in the fennel and placebo groups, respectively; p<0.001). None of the intervention or control groups reported any side effects from fennel or placebo. Go to: Discussion This study aimed to assess the effect of fennel on sexual function in postmenopausal women. Our results showed that all areas of sexual function significantly improved in the fennel group compared to the control group. Foeniculum vulgare or fennel is a plant that has estrogenic effects. This plant can improve milk secretion, promote menstruation, and decrease postmenopausal symptoms in women and andropause symptoms in men [21]. The positive effect of fennel on the vaginal and cervical epithelium of rats has been reported [18]. Jaroenporn et al. conducted a study on 12 postmenopausal cynomolgus macaques with cessation of menstruation for at least 5 years, to compare the effect of a vaginal cream with Puerariamirifica extract and a conjugated equine estrogen cream. Their results showed that this vaginal cream significantly improved vaginal atrophy (an increase in superficial cells and a decrease in the pH of the vagina) similar to conjugated equine estrogen, without any side effects [22]. These results in terms of improving vaginal atrophy are similar to what we found in our study with fennel vaginal cream. A study conducted by Yaralizadeh et al. that evaluated the effect of fennel on vaginal atrophy in postmenopausal women also showed that fennel could significantly increase the number of superficial cells of the vagina, decrease the pH and the objective and subjective symptoms of vaginal atrophy (pallor, itching, dryness and dyspareunia) [15]. In another part of the aforementioned study, the effect of fennel on sexual satisfaction in 60 postmenopausal women was assessed. The results showed that fennel significantly increased sexual satisfaction in postmenopausal women compared to placebo [16]. The results of the present study are in line with the two studies mentioned above, as all of them demonstrated that fennel could significantly decrease vaginal atrophy and improve sexual satisfaction and also sexual function. A study conducted by Abdali et al. compared an oral tablet of fennel with Hypericumperforatum regarding their effect on climacteric symptoms and sexual activity in 120 postmenopausal women aged 45-60 years. The results of this study showed that the total score of sexual function in both fennel and Hypericum groups increased significantly compared to the placebo group (increased from 18.2±2.61 to 22.78± 2.61 in the Hypericum group, from 18.38±2.29 to 22.51±2.25 in the fennel group and from 19.39±3.18 to 20.79±3 in the placebo group; p<0.01) [23]. These results are similar to what we found in our study. However, there is a difference between these two studies as Abdali et al. used an oral form of fennel and we used a vaginal cream, and furthermore, they only assessed the total score of sexual function, while we assessed different domains of sexual activity plus the total score of sexual activity. Also, the total score of sexual function in our study improved better than it did in Abdali et al.’s study. Strength and limitations of study Fennel vaginal cream was introduced in the first part of this study [15] and patented in Iran (Ref. No.: 034356). Also, a patent application has been filled for it at the United States Department of Commerce (United States Patent and Trademark Office) (Confirmation No.: 5013). One of the limitations of this study was that talking about sexual matters in the Iranian culture is not simple. Participants may not express their true feelings about sexuality. We only relied on participants’ responses to the questions in the FSFI. We only followed participants for 8 weeks. Perhaps with a longer follow-up, the advantages and disadvantages of the fennel vaginal cream could be better assessed. Go to: Conclusion According to our results, fennel vaginal cream is an effective means to improve the sexual activity of postmenopausal women. The use of this product in women who have sexual dysfunction and contraindications for hormone therapy is recommended. Acknowledgment This study was part of the master thesis of MY. All expenses of this research were provided by Ahvaz Jundishapur University of Medical Sciences. We would like to thank all postmenopausal women who participated in this study. Source of funding: Ahvaz Jundishapur University of Medical Sciences provided all expenses of this research. Disclosures: The authors declare that there is no conflict of interest. Go to: References 1. Butler L, Santoro N. The reproductive endocrinology of the menopausal transition. Steroids. 2011;76(7):627–635. [PMC free article] [PubMed] 2. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Am J Hum Biol. 1992;4(1):37–46. Available from: http://doi.wiley.com/10.1002/ajhb.1310040107 . [PubMed] 3. Santoro N, Randolph JF. Reproductive hormones and the menopause transition. Obstet Gynecol Clin North Am. 2006;38(3):455–466. [PMC free article] [PubMed] 4. Addis IB, Van Den Eeden SK, Wassel-Fyr CL, Vittinghoff E, Brown JS, Thom DH. Sexual activity and function in middle-aged and older women. Obstet Gynecol. 2006;107(4):755–764. [PMC free article] [PubMed] 5. Jamali S, Javadpour S, Mosalanejad L, Parnian R. Attitudes About Sexual Activity Among Postmenopausal Women in Different Ethnic Groups: A Cross-sectional Study in Jahrom, Iran. . J Reprod Infertil. 2016;17(1):47–55. [PMC free article] [PubMed] 6. Redmond GP. Hormones and sexual function. Int J Fertil Womens Med. 1998;44(4):193–197. [PubMed] 7. Lindahl SH. Reviewing the options for local estrogen treatment of vaginal atrophy. Int J Womens Health. 2014;6:307–312. [PMC free article] [PubMed] 8. Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, Aragaki AK, Shumaker SA, Brzyski RG, LaCroix AZ, Granek IA, Valanis BG. Effects of Estrogen plus Progestin on Health-Related Quality of Life. N Engl J Med. 2003;348(19):1839–1854. [PubMed] 9. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002 Jul 17;288(3):321–333. [PubMed] 10. Shin B-C, Lee MS, Yang EJ, Lim H-S, Ernst E, Laumann E. Maca (L. meyenii) for improving sexual function: a systematic review. BMC Complement Altern Med. 2010;10(1):44–44. [PMC free article] [PubMed] 11. Ng C, Lee C, Ho AL, Lee VWY. Effect of Niacin on Erectile Function in Men Suffering Erectile Dysfunction and Dyslipidemia. J Sex Med. 2011;8(10):2883–2893. [PubMed] 12. US Department of Agriculture NRCS. Classification for Kingdom Plantae Down to Genus Foeniculum Mill. 2015 http://plants.usda.gov/java/ClassificationServlet?source=display&classid=FOENI . 13. Saharkhiz MJ, Tarakeme A. Essential oil content and composition of fennel (Foeniculum vulgare L.) fruits at different stages of development . J Essent Oil Bear Plants. 2011;14(5):605–609. 14. Akha O, Rabiei K, Kashi Z, Bahar A, Zaeif-Khorasani E, Kosaryan M, Saeedi M, Ebrahimzadeh MA, Emadian O. The effect of fennel (Foeniculum vulgare) gel 3% in decreasing hair thickness in idiopathic mild to moderate hirsutism, A randomized placebo controlled clinical trial. Casp J Intern Med. 2014;5(1):26–29. [PMC free article] [PubMed] 15. Yaralizadeh M, Abedi P, Najar S, Namjoyan F, Saki A. Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial. Maturitas. 2016;84:75–80. [PubMed] 16. Shahnaz Najar, Masumeh Yaralizadeh, Parvin Abedi AS. The effect of vaginal cream of fennel on dyspareunia and sexual satisfaction in postmenopausal women; A randomized controlled trial. IJOGI. 2015;18(171):8–16. 17. Lima SMRR, Yamada SS, Reis BF, Postigo S, Galvão da Silva MAL, Aoki T. Effective treatment of vaginal atrophy with isoflavone vaginal gel. Maturitas. 2013;74(3):252–258. [PubMed] 18. Nourman L, Alboghobaish N NH. Comparison the effect of fennel extract and estradiaol valerat on the cervix and vagina after ovarectomy in rat. The 11th Veterinary Congress. 2011 19. Rosen R, Brown C, Heiman J, Leiblum S, et al. The Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual Function. J Sex Marital Ther. 2000;26(2):191–208. [PubMed] 20. Fakhri A, Pakpour AH, Burri A, Morshedi H, Zeidi IM. The Female Sexual Function Index: Translation and Validation of an Iranian Version. J Sex Med. 2012;9(2):514–523. [PubMed] 21. Albert-Puleo M. Fennel and anise as estrogenic agents. J Ethnopharmacol. 1980;2(4):337–344. [PubMed] 22. Jaroenporn S, Urasopon N, Watanabe G, Malaivijitnond S. Improvements of vaginal atrophy without systemic side effects after topical application of Pueraria mirifica, a phytoestrogen-rich herb, in postmenopausal cynomolgus macaques. J Reprod Devl. 2014;60(3):238–245. [PMC free article] [PubMed] 23. Abdali K, Dowran P, Kasraian M, Tabatabaei H. Comparison of the effect of Foeniculum vulgare and St John’s wort (Hypericum perforatum) on the climacteric symptoms and sexual activity in menopausal woman attending in selected gynecology. Int J Adv Biotechnol Res. 2013;7:148–154. Articles from Journal of Medicine and Life are provided here courtesy of Carol Davila - University Press